PRESS RELEASE published on 06/26/2025 at 17:40, 11 months 23 days ago VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue entirely dedicated to supporting the commercial expansion of its offering of dietary supplements Valbiotis announces success of €6.9 million rights issue to support commercial expansion of dietary supplements. Strong interest from shareholders Shareholders Rights Issue Valbiotis Dietary Supplements Commercial Expansion
BRIEF published on 06/06/2025 at 08:05, 1 year ago Valbiotis Announces Capital Increase of €6.9 Million Capital Increase Valbiotis Dietary Supplements Subscription Rights Commercial Strategy
PRESS RELEASE published on 06/06/2025 at 08:00, 1 year ago VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintained preferential subscription rights for a gross amount of nearly €6.9 million, secured by subscription commitments of 75 Valbiotis announces a capital increase of nearly €6.9 million with preferential subscription rights, aiming to finance its commercial strategy and sales growth of health supplements. Subscription period from 12 to 24 June 2025 Capital Increase Valbiotis Subscription Rights Commercial Strategy Health Supplements
BRIEF published on 06/02/2025 at 22:53, 1 year ago Valbiotis: Information on Share Capital and Voting Rights Share Capital Voting Rights Euronext Growth Valbiotis AMF Regulation
BRIEF published on 06/02/2025 at 22:53, 1 year ago VALBIOTIS: Information on Share Capital and Voting Rights Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossing
BRIEF published on 05/22/2025 at 17:45, 1 year ago Valbiotis to Launch ValbiotisPRO® Cardio-circulation on 2 June Valbiotis Dietary Supplements Pharmacy Network Cardio-circulation Tensodrive
PRESS RELEASE published on 05/22/2025 at 17:40, 1 year ago VALBIOTIS SA: Valbiotis to launch ValbiotisPRO® Cardio-circulation on 2 June Valbiotis announces the launch of ValbiotisPRO® Cardio-circulation on 2 June, expanding its range of scientifically tested dietary supplements to support cardiometabolic balance. Multichannel marketing strategy accelerates with listings in supplemental insurance companies Dietary Supplements Scientific Multichannel Marketing ValbiotisPRO® Cardio-circulation Cardiometabolic Balance
BRIEF published on 05/14/2025 at 17:13, 1 year 1 month ago VALBIOTIS SA: Data on voting rights and shares as of April 30, 2025 Share Capital Voting Rights Euronext Growth Valbiotis Crossing Thresholds
BRIEF published on 05/06/2025 at 17:45, 1 year 1 month ago Valbiotis: Strong Market Entry with Strategic Expansion and New Launches Sales Growth Valbiotis Product Launches Strategic Goals Pharmacy Network
PRESS RELEASE published on 05/06/2025 at 17:40, 1 year 1 month ago VALBIOTIS SA: Strong Start to the Year in Line with the Company Roadmap: Expanding Sales Network, New Product Launches, & Growth in Pharmacy and Online Sales Valbiotis reports strong start to the year with expanding sales network, new product launches, and growth in pharmacy and online sales. Company roadmap on track, strategic targets confirmed Valbiotis Online Sales Product Launches Sales Network Pharmacy
Published on 06/20/2026 at 01:00, 5 hours 21 minutes ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 6 hours 21 minutes ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 1 hour ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 5 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 5 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 06:00, 21 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 10 hours 3 minutes ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 11 hours 20 minutes ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 18:00, 12 hours 21 minutes ago Successful issue of a CHF 100 million green bond
Published on 06/19/2026 at 19:33, 10 hours 48 minutes ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 10 hours 57 minutes ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 1 day 12 hours ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 1 day 12 hours ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 1 day 12 hours ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026